ASX:OBJOBJ Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding OBJ Limited Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlines OBJ Limited develops dermaportation and enhanced transdermal polymer technologies for use in the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors in Australia. The company provides partnering services and product solutions for technologies in transdermal and intra-dermal drug delivery; therapeutic and dermatological skincare; cosmetic and non-medicinal active ingredient; oral health; haircare solutions utilizing enhanced brushes and applicators; high penetration surface hygiene technologies; fabric and carpet cleaning technologies; and industrial surface interface systems. It offers various technology platforms, such as Static Micro-arrays, a film based micro-array technology for patches, masks, dressings, and other topical applications; and Field in Motion Micro-arrays, a magnetic micro-array film for use in brushes, applicators, and wipes; Dermaportation, a product development platform for a range of commercial applications; eSkin, a multi-product delivery system that offers a range of product-specific, time-varying magnetic fields for enhanced delivery of multiple formulations; and measured dose delivery devices and packaging solutions. OBJ Limited was founded in 2004 and is based in Leederville, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for OBJ. Previous Next 0.0 Community Rank Outperform VotesOBJ has received 0 “outperform” votes. (Add your “outperform” vote.)Underperform VotesOBJ has received 0 “underperform” votes. (Add your “underperform” vote.)MarketBeat's community ratings are surveys of what our community members think about OBJ and other stocks. Vote “Outperform” if you believe OBJ will outperform the S&P 500 over the long term. Vote “Underperform” if you believe OBJ will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldOBJ does not currently pay a dividend.Dividend GrowthOBJ does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, OBJ insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.00 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolASX:OBJ Previous Symbol CUSIPN/A CIKN/A Webwww.obj.com.au Phone61 8 9443 3011Debt Debt-to-Equity Ratio20.84 Current Ratio1.43 Quick Ratio1.43Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$1.98 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.01 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive OBJ News and Ratings via Email Sign-up to receive the latest news and ratings for OBJ and its competitors with MarketBeat's FREE daily newsletter. OBJ (ASX:OBJ) Frequently Asked Questions Has OBJ been receiving favorable news coverage? News headlines about OBJ stock have trended somewhat negative on Sunday, InfoTrie reports. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. OBJ earned a news sentiment score of -1.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news aboutOBJ. Who are some of OBJ's key competitors? Some companies that are related to OBJ include BioMark Diagnostics (BUX), Carl Data Solutions (CRL), EPIGENOMICS AG/S (EPGNY), Eternity Healthcare (ETAH), Imagin Medical (IME), Medical Imaging (MEDD), Parallax Health Sciences (PRLX), Profound Medical (PRN), Sartorius (SRT3) and Siemens Healthineers (SMMNY). View all competitors. Who are OBJ's key executives? OBJ's management team includes the following people: Mr. Jeffrey David Edwards, Founder, MD, Technical Director & Exec. DirectorMr. Paul Peros, Chief Exec. OfficerDr. Matthew McIldowie, Chief Scientific OfficerMr. John Joseph Palermo B.Bus, CA, FCA, ASCA, J.P., ACIS, AGIA, Snr, Company Sec.Dr. Michael Roberts, Scientific Adviser What is OBJ's stock symbol? OBJ trades on the ASX under the ticker symbol "OBJ." How big of a company is OBJ? OBJ has a market capitalization of $0.00 and generates $1.98 million in revenue each year. What is OBJ's official website? The official website for OBJ is www.obj.com.au. How can I contact OBJ? The company can be reached via phone at 61 8 9443 3011. This page was last updated on 5/31/2020 by MarketBeat.com Staff
